First humans take experimental Brain-Activity drug
NCT ID NCT06705088
Summary
This is the first study to test a new oral drug called SUVN-I6107 in people. It aims to check if the drug is safe, how the body processes it, and if it affects brain activity in healthy volunteers. The study involves giving single and multiple doses to up to 64 healthy adults and carefully monitoring their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Site
RECRUITINGSan Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.